Breaking News, Collaborations & Alliances

Radius Health, 3M Expand Alliance

Will use 3M's Microstructured Transdermal System technology against osteoporosis

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Radius Health, Inc. and 3M Drug Delivery Systems have entered an exclusive partnership for the development and commercialization of BA058-transdermal (TD), a synthetic peptide analog of human parathyroid hormone related protein (hPTHrP), a bone building anabolic compound, for the potential treatment of osteoporosis. This agreement expands the development agreement entered in May 2011 for BA058-TD.   BA058-TD is being studied in a Phase II trial in healthy postmenopausal women with osteoporosis. ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters